Question 1 of 30
A pharmaceutical company receives notification from its primary glass vial supplier that a critical parameter in their glass melting process has been adjusted to improve energy efficiency. This adjustment, while not violating the supplier\'s own quality system, has the potential to subtly alter the chemical composition and surface properties of the glass. As an internal auditor for the pharmaceutical manufacturer, tasked with ensuring compliance with ISO 15378:2017, what is the most appropriate immediate action to recommend regarding the primary packaging material?
Initiate a re-validation process for the affected primary packaging material to confirm its continued suitability and performance.
Conduct a thorough review of the supplier's updated process documentation and accept the change if it aligns with the supplier's internal quality standards.
Request a detailed impact assessment from the supplier and await their conclusion before taking any further action.
Implement enhanced incoming inspection testing for the next three batches of vials to monitor for any deviations.

Preparing for ISO 15378:2017 - Primary Packaging for Medicines Internal Auditor? Now land the interview.

73% of qualified candidates get rejected because of weak resumes. Build an ATS-optimized, recruiter-ready resume in under 5 minutes - free to start.

Build My Resume Free